Log In
Print
BCIQ
Print
Print this Print this
 

BBI503

  Manage Alerts
Collapse Summary General Information
Company Dainippon Sumitomo Pharma Co. Ltd.
DescriptionSmall molecule kinase inhibitors that targets cancer stem cells
Molecular Target Undisclosed
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today